Personalized Hypoglycemia Outpatient Treatment - a Feasibility Study
Recruiting now NCT07094529
Run by Ottawa Hospital Research Institute · for 18 and older · All sexes
What this study is about
This study will offer two study interventions designed to bring on a mild low blood sugar (capillary blood glucose result 3.0 to 3.8 mmol/L), in order to study the effectiveness of each study participant's personal choice of treatment and first recheck time. The two study interventions that the participant can choose to complete (one or both interventions). Based on each participant's own experience with hypoglycemia treatment or their preferences, the participant can choose one of 4 simple carbohydrate treatment quantities, and choose one of 4 capillary blood glucose recheck times.
Who can join (things the study team will check)
✅ You may be able to join if…
- In order to be eligible to participate in this study, an individual must meet all of the following criteria:
- Consent provided
- Age >= 18 years.
- Diagnosed as type 2 diabetes mellitus.
- Type 2 diabetes medications include at least one of the following for at least one month prior to entering the study: sulfonylurea or insulin of any type.
🚫 You may not be able to join if…
- An individual who meets any of the following criteria will be excluded from participation in this study:
- Diagnosed as another form of diabetes mellitus.
- Has a history of hypoglycemia unawareness.
- Had a hypoglycemia event, defined as capillary blood glucose < 3.9 mmol/L within 24 hours prior to the study visit booking time.
Where this trial is running
- The Ottawa Hospital, Ottawa, Ontario, Canada
Who to contact
Cathy Sun, MD MSc · 613-738-8333 · csun@toh.ca
It's completely normal to call and ask questions before deciding anything. Mention the study ID: NCT07094529.
Verify everything on the official ClinicalTrials.gov record. Page updated July 2026.